Total Payments
$7,760
2024 Payments
$5,418
Companies
42
Transactions
142
Medicare Patients
4,499
Medicare Billing
$505,776
Payment Breakdown by Category
Food & Beverage$4,961 (63.9%)
Travel$2,721 (35.1%)
Education$78.12 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,961 | 123 | 63.9% |
| Travel and Lodging | $2,721 | 14 | 35.1% |
| Education | $78.12 | 5 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,613 | 33 | $0 (2024) |
| Inari Medical, Inc. | $609.93 | 3 | $0 (2023) |
| Boston Scientific Corporation | $371.51 | 6 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $365.28 | 4 | $0 (2022) |
| Abbott Laboratories | $282.46 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $258.94 | 12 | $0 (2024) |
| Smith+Nephew, Inc. | $252.85 | 7 | $0 (2024) |
| Organogenesis Inc. | $215.72 | 5 | $0 (2024) |
| Sandoz Inc. | $176.52 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $153.49 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,418 | 108 | Medtronic, Inc. ($3,442) |
| 2023 | $1,612 | 21 | Inari Medical, Inc. ($424.54) |
| 2022 | $474.16 | 8 | Inari Medical, Inc. ($185.39) |
| 2021 | $18.12 | 1 | United Therapeutics Corporation ($18.12) |
| 2018 | $91.99 | 1 | Actelion Pharmaceuticals US, Inc. ($91.99) |
| 2017 | $145.78 | 3 | Actelion Pharmaceuticals US, Inc. ($104.00) |
All Payment Transactions
142 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.36 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/12/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Heart Failure | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: ANTIBIOTIC | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Smith+Nephew, Inc. | GRAFIX (Medical Supply) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Other Advanced Wound Management | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Cardiology | ||||||
| 10/14/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: ANTIBIOTIC | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Obesity | ||||||
| 09/17/2024 | Organogenesis Inc. | PURAPLY AM (Device) | Food and Beverage | In-kind items and services | $39.01 | General |
| Category: WOUND CARE | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $211.07 | General |
| Category: Vascular | ||||||
| 09/03/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $24.30 | General |
| Category: Coronary | ||||||
| 08/30/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/28/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/27/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Other Advanced Wound Management | ||||||
| 08/26/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Obesity | ||||||
| 08/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 470 | 807 | $438,136 | $64,857 |
| 2022 | 20 | 1,101 | 2,567 | $1.2M | $128,372 |
| 2021 | 27 | 1,500 | 3,050 | $1.4M | $158,490 |
| 2020 | 25 | 1,428 | 3,895 | $1.6M | $154,058 |
Total Patients
4,499
Total Services
10,319
Medicare Billing
$505,776
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 331 | $163,651 | $28,088 | 17.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 74 | 231 | $115,500 | $20,160 | 17.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 49 | $42,875 | $6,277 | 14.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $15,340 | $2,520 | 16.4% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $45,600 | $2,234 | 4.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 13 | 52 | $7,540 | $1,968 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 21 | $10,290 | $1,403 | 13.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 24 | 24 | $22,800 | $1,117 | 4.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $3,960 | $676.80 | 17.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 39 | 46 | $10,580 | $414.00 | 3.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 268 | 350 | $162,750 | $30,395 | 18.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 127 | 383 | $183,840 | $28,713 | 15.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 22 | 27 | $164,700 | $10,336 | 6.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 41 | 164 | $23,780 | $7,042 | 29.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 46 | $38,410 | $6,795 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 122 | $38,186 | $6,560 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $35,037 | $5,869 | 16.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 34 | 34 | $93,500 | $4,886 | 5.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 41 | 41 | $23,390 | $4,043 | 17.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 51 | $23,715 | $3,854 | 16.3% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 25 | 26 | $79,820 | $3,597 | 4.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 73 | 73 | $69,350 | $3,079 | 4.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 18 | 18 | $68,040 | $2,835 | 4.2% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2022 | 34 | 68 | $12,240 | $2,486 | 20.3% |
| 93455 | Insertion of tube in bypass graft for diagnosis with review by radiologist | Facility | 2022 | 14 | 14 | $49,980 | $2,207 | 4.4% |
About Dr. Ramagopal Tumuluri, MD
Dr. Ramagopal Tumuluri, MD is a Cardiovascular Disease healthcare provider based in Brookfield, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063489615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramagopal Tumuluri, MD has received a total of $7,760 in payments from pharmaceutical and medical device companies, with $5,418 received in 2024. These payments were reported across 142 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,961).
As a Medicare-enrolled provider, Tumuluri has provided services to 4,499 Medicare beneficiaries, totaling 10,319 services with total Medicare billing of $505,776. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Brookfield, WI
- Active Since 03/02/2006
- Last Updated 04/08/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1063489615
Products in Payments
- VENASEAL (Device) $1,240
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $1,165
- TURBOHAWK (Device) $1,017
- FLOWTRIEVER CATHETER, S (Device) $394.07
- GRAFIX PL (Medical Supply) $239.69
- CT THROMBECTOMY SYSTEM KIT (Device) $215.86
- PERCLOSE PROSTYLE (Device) $211.07
- OPSUMIT MACITENTAN (Drug) $195.99
- TREPROSTINIL (Drug) $176.52
- LEQVIO (Drug) $172.04
- ONYX FRONTIER (Device) $170.94
- UPTRAVI (Drug) $169.29
- Indigo System (Device) $119.01
- FARXIGA (Drug) $112.67
- Barostim Neo System (Device) $104.22
- Ozempic (Drug) $88.79
- ENTRESTO (Drug) $86.90
- Artis zee multi-purpose (Device) $83.93
- CAMZYOS (Drug) $81.56
- ONPATTRO (Drug) $71.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brookfield
Dr. Daniel Hemsworth, Md, MD
Cardiovascular Disease — Payments: $4,830
Cardiovascular Disease $4,830
Dr. David Groden, M.d, M.D
Cardiovascular Disease — Payments: $314.34
Cardiovascular Disease $314.34
Dr. Robert Ninneman, Md, MD
Cardiovascular Disease
Cardiovascular Disease
Dr. Lisa Baratta, Md, MD
Cardiovascular Disease
Cardiovascular Disease
Dr. Timothy Hess, M.d, M.D
Cardiovascular Disease
Cardiovascular Disease